Item request has been placed!

Item request cannot be made.

Processing Request

Search Results

Display Settings

Results per page: 10

Sort By: Relevance

Filter

Your Filters

Publication : haemophilia

Reset filters

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Plasma‐derived human factor X concentrate for the treatment of patients with hereditary factor X deficiency.

Authors : Escobar, Miguel A.¹ (AUTHOR) ; Kavakli, Kaan² (AUTHOR)

Source: Haemophilia. Jan2024, Vol. 30 Issue 1, p59-67. 9p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Preclinical development and characterization of a human plasma‐derived high‐purity factor X concentrate for therapeutic use.

Authors : Lloyd, Joanne¹ (AUTHOR); Feldman, Peter¹ (AUTHOR)

Source: Haemophilia. Nov2023, Vol. 29 Issue 6, p1394-1409. 16p.

Record details

Read Online Read More Add to Saved list

Academic Journal

In vitro evaluation of global coagulation potentials in the co‐presence of plasma‐derived factors Viia/X products (Byclot®) and emicizumab in patients with haemophilia A and inhibitors and acquired haemophilia A: A pilot study.

Authors : Nakajima, Yuto^1,2 (AUTHOR) ; Takami, Eisuke³ (AUTHOR); Nakano, Hirotoshi³ (AUTHOR)

Source: Haemophilia. Sep2022, Vol. 28 Issue 5, pe149-e152. 4p. 2 Charts.

Record details

Read Online Read More Add to Saved list

Academic Journal

Long‐term follow‐up of patients with congenital thrombotic thrombocytopenia purpura receiving a plasma‐derived factor VIII (Koate) that contains ADAMTS13.

Authors : Chrisentery‐Singleton, Tammuella^1,2 (AUTHOR) ; Boggio, Lisa N.³ (AUTHOR); Carcao, Manuel D.⁴ (AUTHOR)

Source: Haemophilia. Nov2023, Vol. 29 Issue 6, p1638-1645. 8p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Targeting a higher plasma VWF level at time of delivery in pregnant individuals with von Willebrand disease: Outcomes at a single‐institution cohort study.

Authors : Lim, Ming Y.¹ (AUTHOR) ; Rodgers, George M.¹ (AUTHOR); Branch, D. Ware² (AUTHOR)

Source: Haemophilia. Mar2024, Vol. 30 Issue 2, p470-477. 8p.

Record details

Read Online Read More Add to Saved list

Academic Journal

In vitro field study and worldwide survey assessing how clinical haemostasis laboratories analyse recombinant and plasma‐derived von Willebrand factor products.

Authors : Turecek, Peter L.¹ (AUTHOR) ; Ilk, Reinhard² (AUTHOR); Gritsch, Herbert¹ (AUTHOR)

Source: Haemophilia. Jan2024, Vol. 30 Issue 1, p151-160. 10p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Combined intra‐articular injections of hyaluronic acid and platelet‐rich plasma for the treatment of haemophilic arthropathy: A case series study.

Authors : Liou, I‐Hsiu¹ (AUTHOR); Lu, Ling‐Ying² (AUTHOR); Lin, Kuan‐Yu³ (AUTHOR)

Source: Haemophilia. Mar2021, Vol. 27 Issue 2, pe291-e294. 4p. 2 Charts.

Record details

Read Online Read More Add to Saved list

Academic Journal

Coagulation potentials of plasma‐derived factors VIIa and X mixture (Byclot®) evaluated by global coagulation assay in patients with acquired haemophilia A.

Authors : Takeyama, Masahiro^1,2 (AUTHOR) ; Furukawa, Shoko¹ (AUTHOR); Ogiwara, Kenichi¹ (AUTHOR)

Source: Haemophilia. Jan2024, Vol. 30 Issue 1, p249-252. 4p.

Record details

Read Online Read More Add to Saved list

Academic Journal

An open‐label, multi‐centre, post‐marketing study to assess the efficacy and safety of a plasma‐derived VWF/FVIII concentrate in patients with von Willebrand disease.

Authors : Miesbach, Wolfgang¹ (AUTHOR) ; Halimeh, Susan² (AUTHOR); Platokouki, Helen³ (AUTHOR)

Source: Haemophilia. Jan2024, Vol. 30 Issue 1, p236-240. 5p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Evaluation of thromboelastometry, thrombin generation and plasma clot lysis time in patients with bleeding of unknown cause: A prospective cohort study.

Authors : Veen, Caroline S. B.¹ (AUTHOR); Huisman, Elise J.² (AUTHOR); Cnossen, Marjon H.² (AUTHOR)

Source: Haemophilia. May2020, Vol. 26 Issue 3, pe106-e115. 10p. 3 Diagrams, 2 Charts.

Record details

Read Online Read More Add to Saved list

Search Results

Your Filters

Plasma‐derived human factor X concentrate for the treatment of patients with hereditary factor X deficiency.

Preclinical development and characterization of a human plasma‐derived high‐purity factor X concentrate for therapeutic use.

In vitro evaluation of global coagulation potentials in the co‐presence of plasma‐derived factors Viia/X products (Byclot®) and emicizumab in patients with haemophilia A and inhibitors and acquired haemophilia A: A pilot study.

Long‐term follow‐up of patients with congenital thrombotic thrombocytopenia purpura receiving a plasma‐derived factor VIII (Koate) that contains ADAMTS13.

Targeting a higher plasma VWF level at time of delivery in pregnant individuals with von Willebrand disease: Outcomes at a single‐institution cohort study.

In vitro field study and worldwide survey assessing how clinical haemostasis laboratories analyse recombinant and plasma‐derived von Willebrand factor products.

Combined intra‐articular injections of hyaluronic acid and platelet‐rich plasma for the treatment of haemophilic arthropathy: A case series study.

Coagulation potentials of plasma‐derived factors VIIa and X mixture (Byclot®) evaluated by global coagulation assay in patients with acquired haemophilia A.

An open‐label, multi‐centre, post‐marketing study to assess the efficacy and safety of a plasma‐derived VWF/FVIII concentrate in patients with von Willebrand disease.

Evaluation of thromboelastometry, thrombin generation and plasma clot lysis time in patients with bleeding of unknown cause: A prospective cohort study.

Contact

Follow us